Get the Stockscreener App
11.28
0.64%
0.1014
Dynavax Technologies Corp stock is traded at $11.28, with a volume of 342.91K.
It is up +0.64% in the last 24 hours and up +8.39% over the past month.
Dynavax Technologies Corp is a biopharmaceutical company. The company focuses on leveraging the power of the body's innate and adaptive immune responses through toll-like receptor stimulation. Its current product candidates are being investigated for use in multiple cancer indications as a vaccine for the prevention of HEPLISAV-B (Hepatitis B Vaccine (Recombinant), Adjuvanted), operates in the business segment of discovery, development, and commercialization of novel vaccines. Its Toll-like Receptor Immune Modulation Platform technology plays a vital role in innate immunity and subsequent adaptive immunity. The company generates the vast majority of its revenue from the sale of its CpG 1018 product and HEPLISAV-B.
See More
Previous Close:
$11.18
Open:
$11.21
24h Volume:
342.91K
Relative Volume:
0.20
Market Cap:
$1.33B
Revenue:
$260.81M
Net Income/Loss:
$20.48M
P/E Ratio:
86.78
EPS:
0.13
Net Cash Flow:
$22.67M
1W Performance:
+1.00%
1M Performance:
+8.39%
6M Performance:
+14.81%
1Y Performance:
-9.41%
1-Day Range:
$11.17
$11.38
1-Week Range:
$10.69
$11.38
52-Week Range:
$9.20
$14.63
Dynavax Technologies Corp Stock (DVAX) Company Profile
Name
Dynavax Technologies Corp
Sector
Phone
(510) 848-5100
Address
2100 POWELL STREET, EMERYVILLE, CA
Compare DVAX with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
DVAX
Dynavax Technologies Corp
|
11.29 | 1.31B | 260.81M | 20.48M | 22.67M | 0.13 |
|
ZTS
Zoetis Inc
|
120.96 | 53.79B | 9.40B | 2.65B | 2.24B | 5.935 |
|
TAK
Takeda Pharmaceutical Co Adr
|
14.27 | 45.18B | 29.63B | 260.53M | 5.51B | 0.0788 |
|
HLN
Haleon Plc Adr
|
9.825 | 43.95B | 14.26B | 1.98B | 2.47B | 0.4327 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
24.77 | 27.78B | 16.70B | -157.13M | 1.19B | -0.1446 |
|
UTHR
United Therapeutics Corp
|
468.86 | 20.44B | 3.08B | 1.24B | 1.07B | 25.61 |
Dynavax Technologies Corp Stock (DVAX) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Feb-11-25 | Downgrade | Goldman | Neutral → Sell |
| Feb-01-24 | Initiated | Goldman | Neutral |
| Sep-27-22 | Initiated | JMP Securities | Mkt Outperform |
| Jan-06-22 | Resumed | Goldman | Buy |
| Aug-06-21 | Initiated | Goldman | Buy |
| Aug-07-20 | Reiterated | H.C. Wainwright | Buy |
| Aug-03-20 | Reiterated | H.C. Wainwright | Buy |
| Jun-15-20 | Initiated | Evercore ISI | Outperform |
| Oct-18-19 | Initiated | H.C. Wainwright | Buy |
| Jul-11-19 | Upgrade | Cantor Fitzgerald | Neutral → Overweight |
| Feb-27-19 | Reiterated | Cantor Fitzgerald | Overweight |
| May-10-18 | Upgrade | JP Morgan | Neutral → Overweight |
| Mar-08-18 | Reiterated | Cantor Fitzgerald | Overweight |
| Feb-14-18 | Downgrade | JP Morgan | Overweight → Neutral |
| Sep-25-17 | Reiterated | RBC Capital Mkts | Outperform |
| Sep-15-17 | Initiated | Cantor Fitzgerald | Overweight |
| Jul-31-17 | Upgrade | JP Morgan | Neutral → Overweight |
| Jul-31-17 | Upgrade | RBC Capital Mkts | Sector Perform → Outperform |
| May-09-17 | Reiterated | RBC Capital Mkts | Sector Perform |
| Apr-28-16 | Downgrade | RBC Capital Mkts | Outperform → Sector Perform |
| Apr-27-16 | Downgrade | JP Morgan | Overweight → Neutral |
| Nov-30-15 | Initiated | RBC Capital Mkts | Outperform |
| Nov-25-13 | Upgrade | MLV & Co | Hold → Buy |
| Feb-25-13 | Downgrade | MLV & Co | Buy → Hold |
| Nov-16-12 | Reiterated | MLV & Co | Buy |
View All
Dynavax Technologies Corp Stock (DVAX) Latest News
Dynavax Technologies Corp (DYF1.SG) Stock Price, News, Quote & History - Yahoo! Finance Canada
Dynavax Technologies Corporatio (DVAX) Stock forecasts - Yahoo Finance UK
Dynavax Technologies Corporation (0IDA.L) Stock Price, News, Quote & History - Yahoo! Finance Canada
Is Dynavax Technologies Corporation (DYF1) stock a defensive play amid uncertainty2025 Trading Volume Trends & Accurate Trade Setup Notifications - newser.com
Dynavax to Participate at the 8th Annual Evercore Healthcare Conference - Yahoo Finance
Why Dynavax Technologies Corporation (DYF1) stock remains top ratedRate Hike & Low Risk Entry Point Tips - newser.com
Can Dynavax Technologies Corporation stock deliver consistent earnings growthWeekly Risk Summary & Precise Trade Entry Recommendations - newser.com
Is Dynavax Technologies Corporation showing signs of accumulation2025 Price Targets & Long-Term Investment Growth Plans - newser.com
Why Dynavax Technologies Corporation (DYF1) stock fits value portfoliosTake Profit & Technical Pattern Based Buy Signals - newser.com
Campbell & CO Investment Adviser LLC Sells 24,624 Shares of Dynavax Technologies Corporation $DVAX - Defense World
Can Dynavax Technologies Corporation stock reach $100 price targetSell Signal & Smart Allocation Stock Tips - newser.com
How Dynavax Technologies Corporation stock responds to policy changesWeekly Market Report & Low Drawdown Momentum Ideas - newser.com
Vaxart, Inc. Enters Exclusive License Agreement with Dynavax for COVID-19 Oral Vaccine Candidate, Completes Phase 2b Enrollment and Reports Q3 2025 Financial Results - Quiver Quantitative
Vaxart Provides Business Update and Reports Third Quarter 2025 Financial Results - Yahoo Finance
What institutional flow reveals about Dynavax Technologies CorporationWeekly Profit Report & Low Drawdown Investment Ideas - newser.com
Is Dynavax Technologies Corporation (DYF1) stock protected from inflationJuly 2025 Setups & AI Enhanced Trading Signals - newser.com
What dividend safety score for Dynavax Technologies Corporation stockInflation Watch & Verified Technical Signals - newser.com
What analysts say about Dynavax Technologies Corporation DYF1 stockDividend Growth Stocks & Trusted Financial Advisors at No Cost - earlytimes.in
What MACD and RSI say about Dynavax Technologies CorporationDollar Strength & Growth Focused Investment Plans - newser.com
Dynavax Technologies Corporatio (DVAX) Stock Forecasts - Yahoo Finance
Dynavax Technologies Corporation (NASDAQ:DVAX) Q3 2025 Earnings Call Transcript - Insider Monkey
Why Dynavax Technologies (DVAX) Is Up 5.7% After Launching a $100 Million Buyback and Raising Guidance - Yahoo Finance
Dynavax targets 60% U.S. hepatitis B market share by 2030 amid new COVID-19 vaccine deal and expanded share repurchase - MSN
Predicting Dynavax Technologies Corporation trend using moving averagesJuly 2025 Update & Fast Exit Strategy with Risk Control - newser.com
Will Dynavax Technologies Corporation stock remain a Wall Street favoriteWeekly Gains Summary & Weekly Breakout Stock Alerts - newser.com
Chart overlay techniques for tracking Dynavax Technologies CorporationEarnings Overview Report & Low Risk High Win Rate Picks - newser.com
Dynavax posts 13% rise in HEPLISAV-B revenue, announces $100 million buyback - Investing.com Nigeria
Dynavax Technologies: Q3 Earnings Snapshot - ctinsider.com
Dynavax Technologies Corp Stock (DVAX) Financials Data
Revenue
Net Income
Cash Flow
EPS
Dynavax Technologies Corp Stock (DVAX) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| Deep Track Biotechnology Maste | 10% Owner |
Aug 21 '25 |
Sale |
11.03 |
1,094,994 |
12,077,784 |
16,696,492 |
| Deep Track Biotechnology Maste | 10% Owner |
Aug 22 '25 |
Sale |
10.59 |
970,143 |
10,273,814 |
15,726,349 |
| Novack David F | President & COO |
Mar 24 '25 |
Option Exercise |
6.80 |
10,000 |
68,050 |
18,078 |
| Novack David F | President & COO |
Mar 24 '25 |
Sale |
14.00 |
10,000 |
140,000 |
8,078 |
6.68%
1.69%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):